You are here  Home  

Leys, D. (FR), MD

Neurological Department, CHU Hospital Roger Salengro, University of Lille, France


Didier Leys is Professor of Neurology and Head of the Neurological Department, CHU Hospital Roger Salengro, University of Lille, France.

Dr Leys’s main research and clinical topics are dementia in stroke patients, atherothrombosis, stroke prevention, the management of modifiable vascular risk factors for stroke prevention, statins in stroke, clinical outcome in young adults with ischaemic stroke and creation of neurovascular units.

Dr Leys is the former chairman of the French Stroke Society (1998-2000). Furthermore he was a member of the executive committee of the European Neurological Society and the European Stroke Council. Dr Leys is one of the contributors of the Recommendations for the Creation of Neuro-Vascular Units. He is a principle investigator in the TAIST (Tinzaparin in acute ischaemic stroke) trial.

Dr Leys is a member of the editorial board of Cerebrovascular Diseases and Journal of Neurology and a reviewer for: the British Medical Journal, Stroke, the Journal of Neurology Neurosurgery and Psychiatry, CNS Drugs, the Journal of Neurology, Cerebrovascular Diseases, European Neurology, La Revue Neurologique, the European Journal of Neurology, Acta Neurologica Belgica. He is a member of the EUSI Executive Committee.

Dr Leys has authored and co-authored more than 180 scientific articles about cerebrovascular diseases in journals such as Stroke, Cerebrovascular Diseases, Revue Neurologique, the Journal of Neurology, Archives of Neurology, the Journal of Neurosciences, and Neurology.

  • ABCD² & Other Scales - Good or Bad?

  • Acute stroke complications

  • Late post stroke complications and monitoring

  • New insights into cervical artery dissection

  • Stroke and dementia

  • Thrombolysis in acute stroke

  • Warfarin may still be the better alternative